Clik here to view.
CORRECTING and REPLACING BeiGene Completes 450 Million RMB (75 Million USD)...
BEIJING In the release dated November 14, 2014, references to “CITIC Capital Partners” should be “CITIC PE”. The boilerplate for CITIC Capital Partners should be replaced with the CITIC PE...
View ArticleClik here to view.
Presbia Flexivue Microlens™ Receives Approval from Korean Ministry of Food...
AMSTERDAM Presbia announced today that its Presbia Flexivue Microlens™ has received regulatory approval from the Korean Ministry of Food and Drug Safety (MFDS) making this new treatment option for...
View ArticleClik here to view.
TechNavio Says Increased Outsourcing Activities Will Positively Affect Profit...
LONDON TechNavio, a tech-focused research firm has published a new report on the Global Oncology Biosimilars Market, which is expected to grow at a CAGR of 29.87 percent from 2014-2018. A good...
View ArticleClik here to view.
Duke University Researchers Visit NCKU for Future Collaboration
TAINAN, Taiwan Mani Daneshmand, Roberto Manson and Dawn E. Bowles from Duke University School of Medicine, United States, visited National Cheng Kung University (NCKU), southern Taiwan, on November...
View ArticleClik here to view.
PharmaEngine Announces the Receipt of US FDA Fast Track Designation for...
TAIPEI, Taiwan PharmaEngine, Inc. (TWO: 4162) and its partner Merrimack Pharmaceuticals, Inc. (NASDAQ: MACK) announced today that MM-398 (nanoliposomal irinotecan injection, also known as PEP02) has...
View ArticleClik here to view.
Duke Surgery, NCKU Work to Better Develop New Cardiac Assist Device
TAINAN, Taiwan Dr. Mani Daneshmand, Dr. Roberto Manson and Dr. Dawn E. Bowles from Duke University School of Medicine, United States, joined a workshop held at the National Cheng Kung University...
View ArticleClik here to view.
Phyathai Nawamin International Hospital Thailand Now Offers Spinal Surgery...
BANGKOK Phyathai Nawamin International Hospital’s Spine and Brain Center now offers the newest and updated medical treatment technique for Spinal Surgery with Advanced Technology of Decompression,...
View ArticleClik here to view.
Cell Signaling Technology Wins “Best Antibodies” and “Most Useful Website” at...
WASHINGTON Cell Signaling Technology, a leading provider of antibodies, kits and services, announced today that it has won two Life Science Industry Awards® for “Best Antibodies” and “Most Useful...
View ArticleClik here to view.
ZOLL Files with Japan’s Pharmaceuticals and Medical Devices Agency for New...
CHELMSFORD, Mass. ZOLL Medical Corporation, a manufacturer of medical devices and related software solutions, announced today that its Japanese subsidiary, Asahi Kasei ZOLL Medical Corp. (AZM), has...
View ArticleClik here to view.
CSTが「最も優れた抗体」および「最も有益なウェブサイト」の部門でライフサイエンス・インダストリー・アワードを受賞
ワシントン （ビジネスワイヤ）– 抗体、キット、サービスを提供する一流企業のセル・シグナリング・テクノロジー（CST）は本日、「最も優れた抗体」（Best Antibodies）および「最も有益なウェブサイト」（Most Useful Website）の2部門でライフサイエンス・インダストリー・アワード（Life Science Industry...
View ArticleClik here to view.
R-Tech Ueno Received Orphan Drug Designation for Unoprostone Isopropyl...
TOKYO R-Tech Ueno (JASDAQ:4573): R-Tech Ueno, Ltd. today announced that we have officially received the Orphan Drug Designation from the Ministry of Health, Labour and Welfare (MHLW) for Unoprostone...
View ArticleClik here to view.
ファインデックス、ソニー製品向け「P-Launcher for HVO」を販売開始
愛媛県松山市 （ビジネスワイヤ） — 株式会社ファインデックス（東証一部：3649 本社：愛媛県松山市三番町4-9-6 社長：相原輝夫）は、ソニー社製のメディカルレコーダーHVOシリーズ向けのデータ取得/連携ツール「P-Launcher for HVO」を、2014年12月1日からソニービジネスソリューション株式会社より販売いたします。...
View ArticleClik here to view.
株式会社東芝が日本で新たに開始するゲノム解析サービスのためにアフィメトリクス社のAxiomプラットフォームを採用
カリフォルニア州サンタクララ発 （ビジネスワイヤ） — アフィメトリクス社（NASDAQ：AFFX）は、株式会社東芝（TYO：6502）ヘルスケア社が新たに開始するゲノム解析サービスのプラットフォームとして、Axiom®ジェノタイピングソリューションが採用されたことを発表します。当社は、株式会社東芝と協働し、Axiomプラットフォーム技術を用いて｢ジャポニカアレイ®...
View ArticleClik here to view.
Toshiba Corporation Selects Affymetrix Axiom Platform for Its Newly Launched...
SANTA CLARA, Calif. Affymetrix (NASDAQ: AFFX) announces its Axiom® Genotyping Solution platform has been selected by Toshiba Corporation’s (TYO: 6502) Healthcare Company as the platform for its...
View ArticleClik here to view.
HanAll Biopharma Co., Ltd. and Open Monoclonal Technology Announce Collaboration
SEOUL, South Korea & PALO ALTO, Calif. HanAll BioPharma Co., Ltd. (HanAll), a public Korean biopharmaceutical company and leader in development of novel biologics and new chemical entities in...
View ArticleClik here to view.
CANbridge Life Sciences Raises $10 Million in Series A Round Led by Qiming...
BEIJING CANbridge Life Sciences, a biopharmaceutical company focused on developing Western drug candidates in China and North Asia, announced that it has raised $10 million in a Series A round from...
View ArticleClik here to view.
Elekta Ltd and Medical Intelligence Medizintechnik GmbH defend claims by...
CRAWLEY, United Kingdom Regulatory News: humediQ GmbH has initiated legal proceedings against two companies in the Elekta (STO:EKTAB) (EKTA-B.ST) group. The dispute relates to an agreement from...
View ArticleClik here to view.
Biogen Idec to Present Data from Hematology Programs, Including ELOCTATE™ and...
CAMBRIDGE, Mass. Biogen Idec (NASDAQ: BIIB) will present data supporting its approved hemophilia therapies at the 56th Annual Meeting of the American Society of Hematology (ASH) taking place in San...
View ArticleClik here to view.
テラヴェクティスが自社レンチウイルスベクター技術の知的財産権をさらに強化
パリ （ビジネスワイヤ） — 完全統合型の創薬・臨床開発バイオテクノロジーを手掛ける企業として治療用ワクチンと免疫療法の開発に傾注するテラヴェクティスは、最初の申請（ウェブサイト）からわずか2年後に欧州特許「Lentiviral Vectors Containing an MHC Class I...
View ArticleClik here to view.
Takeda Announces Formalization of Takeda Oncology to Enhance Discovery,...
CAMBRIDGE, Mass. & OSAKA, Japan Takeda Pharmaceutical Company Limited (TSE:4502) today announced its global oncology business unit, headquartered in Cambridge, MA, will be called Takeda...
View Article